We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+4.07%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$517M
AUM Growth
+$9.2M
(+1.8%)
Cap. Flow
+$14.4M
Cap. Flow
% of AUM
2.78%
Top 10 Holdings %
Top 10 Hldgs %
25.19%
Holding
131
New
22
Increased
34
Reduced
42
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RCM
R1 RCM Inc. Common Stock
RCM
|
+$8.5M |
| 2 |
Option Care Health
OPCH
|
+$8.49M |
| 3 |
Prothena Corp
PRTA
|
+$6.75M |
| 4 |
Alignment Healthcare
ALHC
|
+$6.68M |
| 5 |
Evolent Health
EVH
|
+$6.12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$8.62M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$7.28M |
| 3 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
+$6.42M |
| 4 |
Inspire Medical Systems
INSP
|
+$5.03M |
| 5 |
SGFY
Signify Health, Inc.
SGFY
|
+$4.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.31% |
| 2 | Industrials | 4.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Stryker
SYK
$128B
| $2.27M | 0.44% |
9,300
-1,100
| -11% | -$250K |
|
77
Gilead Sciences
GILD
$161B
| $2.24M | 0.43% |
26,050
-10,350
| -28% | -$820K |
|
78
STAAR Surgical
STAA
$1.22B
| $2.14M | 0.41% |
44,000
-18,500
| -30% | -$1.16M |
|
79
Vertex Pharmaceuticals
VRTX
$119B
| $2.03M | 0.39% |
7,019
-899
| -11% | -$274K |
|
80
Regeneron Pharmaceuticals
REGN
$78.5B
| $1.96M | 0.38% |
2,710
-610
| -18% | -$450K |
|
81
Fate Therapeutics
FATE
$294M
| $1.85M | 0.36% |
183,000
| – | – |
|
82
Humana
HUM
$44.2B
| $1.83M | 0.35% |
3,575
-7,550
| -68% | -$3.97M |
|
83
Zymeworks
ZYME
$1.61B
| $1.51M | 0.29% |
+192,124
| New | +$1.35M |
|
|
EXAI
84
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $1.41M | 0.27% |
+265,098
| New | +$1.67M |
|
85
Scholar Rock
SRRK
$5.59B
| $1.37M | 0.26% |
+151,207
| New | +$1.21M |
|
86
AstraZeneca
AZN
$240B
| $1.36M | 0.26% |
10,005
+250
| +3% | +$31.4K |
|
87
Atea Pharmaceuticals
AVIR
$373M
| $1.35M | 0.26% |
+281,403
| New | +$1.42M |
|
|
PNT
88
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $1.35M | 0.26% |
+185,278
| New | +$1.37M |
|
89
MacroGenics
MGNX
$240M
| $1.34M | 0.26% |
+200,220
| New | +$1.1M |
|
|
ONC
90
BeOne Medicines Ltd
ONC
$32.4B
| $1.32M | 0.25% |
5,980
+200
| +3% | +$36.7K |
|
91
BioXcel Therapeutics
BTAI
$25.7M
| $1.31M | 0.25% |
+3,822
| New | +$924K |
|
92
State Street SPDR S&P Biotech ETF
XBI
$9.62B
| $1.29M | 0.25% |
+15,482
| New | +$1.25M |
|
93
4D Molecular Therapeutics
FDMT
$528M
| $1.2M | 0.23% |
+53,836
| New | +$832K |
|
94
BioAtla
BCAB
$5.49M
| $1.14M | 0.22% |
+2,766
| New | +$1.15M |
|
|
ITOS
95
DELISTED
iTeos Therapeutics
ITOS
| $1.13M | 0.22% |
+57,762
| New | +$1.13M |
|
|
GBIO
96
DELISTED
Generation Bio
GBIO
| $1.08M | 0.21% |
+27,379
| New | +$1.44M |
|
|
EFTR
97
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $1.02M | 0.2% |
95,306
| – | – |
|
98
Illumina
ILMN
$31.1B
| $934K | 0.18% |
4,749
| – | – |
|
|
HZNP
99
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $774K | 0.15% |
6,800
-87,650
| -93% | -$7.28M |
|
100
Incyte
INCY
$24.3B
| $537K | 0.1% |
6,680
-400
| -6% | -$30.6K |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
AAA
TGM
Sectoral Asset Management's Q4 2022 Portfolio in Review
As of Q4 2022, Sectoral Asset Management held 131 positions worth $517M, up 1.8% from $508M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Sectoral Asset Management's Q4 2022 filing shows 22 new, 34 increased, 42 reduced and 11 closed positions. Its largest new stake was Option Care Health: 273,500 shares worth $8.23M. The largest sale was Syneos Health, Inc. Class A Common Stock, an estimated $8.62M.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, down from 96% a quarter earlier, followed by Industrials.
- Sectoral Asset Management's largest Q4 2022 buy was Option Care Health: 273,500 shares worth $8.23M.
- Sectoral Asset Management added most to R1 RCM Inc. Common Stock in Q4 2022, an estimated $8.5M increase.
- Sectoral Asset Management's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $7.28M.
- Sectoral Asset Management fully exited Syneos Health, Inc. Class A Common Stock in Q4 2022, selling an estimated $8.62M.
- Sectoral Asset Management's ten largest holdings make up 25% of its $517M portfolio in Q4 2022.
- Sectoral Asset Management opened 22 new positions and closed 11 in Q4 2022.
- Sectoral Asset Management's portfolio value rose 1.8% quarter-over-quarter to $517M.
Based on Sectoral Asset Management's 13F filing for Q4 2022, filed 10 Feb 2023.